FIB-4 Index

Non-invasive estimate of advanced liver fibrosis
Age (years)
AST
ALT
Platelet count (×10⁹/L)
Enter age, AST, ALT, and platelet count to calculate

About this score

When to use

Estimates the likelihood of advanced liver fibrosis from age, AST, ALT and platelet count — routine tests, without a biopsy. ⁦[1]⁩

Pearls and pitfalls

• It was developed in 832 patients with HIV/hepatitis C coinfection: below 1.45 it had a 90% negative predictive value for advanced fibrosis, above 3.25 a 65% positive predictive value. ⁦[1]⁩
• Values between the two cut-offs are indeterminate and do not classify fibrosis either way. ⁦[1]⁩
Summarised from the numbered sources under Evidence. Check the source before relying on a statement.
Evidence
[1] Original publication
Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. FIB-4 = (age·AST)/(platelets·√ALT); < 1.45 had a 90% negative predictive value for advanced fibrosis and > 3.25 a 65% positive predictive value, avoiding biopsy in ~70% of patients.
Hepatology, 2006
Open source
[2] Validation
McPherson S, Hardy T, Dufour JF, et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. In 634 patients, FIB-4 specificity fell to 35% at age ≥ 65; a lower cut-off of 2.0 was derived and validated for that age group (specificity 70%, sensitivity 77%).
American Journal of Gastroenterology, 2017
Open source
[3] Guideline
Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Recommends FIB-4 as the primary tool to assess the risk of advanced fibrosis.
Hepatology, 2023
Open source
Last reviewed: 2026-10
Report an error in this calculator
MedScore is an educational and clinical decision-support tool. It does not provide a diagnosis, a treatment, or a drug-dosing recommendation, and it does not replace clinical judgement or local guidelines. Confirm every result against the original source before acting on it. The treating clinician remains responsible for all decisions.
Support the developer
MedScore is free on the web and made by a medical student. If it helps you, you can support its development.
Support MedScore